• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Back pain in patients with ductal pancreatic cancer. Its impact on resectability and prognosis after resection.

作者信息

Ridder G J, Klempnauer J

机构信息

Clinic for Abdominal and Transplantation Surgery, Hannover Medical School, Germany.

出版信息

Scand J Gastroenterol. 1995 Dec;30(12):1216-20. doi: 10.3109/00365529509101634.

DOI:10.3109/00365529509101634
PMID:9053977
Abstract

BACKGROUND

Back pain is a frequent and often ominous clinical sign in patients with ductal pancreatic cancer.

METHODS

From 1971 to 1993 a pancreatic carcinoma could be resected in 192 patients, whereas 261 patients underwent either probatory laparotomy alone or palliative bypass procedures. In a retrospective study including uni- and multi-variate survival analysis we have determined the impact of preoperative back pain on both resectability and long-term prognosis after resection.

RESULTS

Among the presenting symptoms of patients with ductal pancreatic cancer back pain was a predictive sign of irresectability. In the presence of preoperative back pain the long-term prognosis after resection of the tumour was also significantly impaired. In a multivariate analysis it could be demonstrated that the prognostic impact of back pain was as strong as the influence of residual tumour, tumour grading, and tumour size.

CONCLUSIONS

Back pain often indicates irresectability of ductal pancreatic carcinoma and also impairs the long-term prognosis even after curative resection.

摘要

相似文献

1
Back pain in patients with ductal pancreatic cancer. Its impact on resectability and prognosis after resection.
Scand J Gastroenterol. 1995 Dec;30(12):1216-20. doi: 10.3109/00365529509101634.
2
Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.胰导管腺癌根治性手术后的随访:无症状复发与生存改善相关。
Eur J Surg Oncol. 2013 Jun;39(6):559-66. doi: 10.1016/j.ejso.2013.02.020. Epub 2013 Mar 14.
3
Pain as a predictor of outcome in patients with operable pancreatic carcinoma.疼痛作为可手术胰腺癌患者预后的预测指标。
Surgery. 1997 Jul;122(1):53-9. doi: 10.1016/s0039-6060(97)90264-6.
4
Relevant factors in the prognosis of ductal pancreatic carcinoma.导管腺癌预后的相关因素。
Acta Chir Scand. 1990 Nov-Dec;156(11-12):781-8.
5
[Multivariate analysis of prognostic factors after resection of ductal pancreatic carcinomas].[导管腺癌切除术后预后因素的多变量分析]
Langenbecks Arch Chir. 1995;380(3):133-8. doi: 10.1007/BF00207717.
6
Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head.壶腹癌切除术后的预后因素:与胰头导管癌相比的多因素生存分析
Br J Surg. 1995 Dec;82(12):1686-91. doi: 10.1002/bjs.1800821233.
7
Prognosis following surgical bypass compared with laparotomy alone in unresectable pancreatic adenocarcinoma.不可切除胰腺腺癌手术旁路与单独剖腹手术的预后比较。
Br J Surg. 2016 Aug;103(9):1200-8. doi: 10.1002/bjs.10190. Epub 2016 Jun 2.
8
[Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].[壶腹癌和胰腺癌的外科治疗结果及其R0切除术后的预后参数]
Zentralbl Chir. 2005 Aug;130(4):353-61. doi: 10.1055/s-2005-836794.
9
[Second-look operation in pancreatic carcinoma previously assessed as unresectable].[对先前评估为不可切除的胰腺癌进行二次探查手术]
Zentralbl Chir. 2010 Feb;135(1):70-4. doi: 10.1055/s-0029-1224749. Epub 2010 Feb 16.
10
Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.临床表现和等待时间目标并不影响胰腺癌患者的预后。
Surgeon. 2010 Oct;8(5):239-46. doi: 10.1016/j.surge.2010.03.001. Epub 2010 Apr 2.

引用本文的文献

1
Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma.利用真实世界数据预测初治胰腺导管腺癌患者种族和民族多样化的多机构队列中的癌症恶病质阶段、生活质量和生存率。
Front Oncol. 2024 Jul 23;14:1362244. doi: 10.3389/fonc.2024.1362244. eCollection 2024.
2
Development and multicentre validation of a prognostic model to predict resectability of pancreatic head malignancy.预测胰头恶性肿瘤可切除性的预后模型的开发与多中心验证
BJS Open. 2018 Jun 8;2(5):319-327. doi: 10.1002/bjs5.79. eCollection 2018 Sep.
3
Indications for staging laparoscopy in pancreatic cancer.
胰腺癌分期腹腔镜检查的适应证
HPB (Oxford). 2016 Jan;18(1):13-20. doi: 10.1016/j.hpb.2015.10.004. Epub 2015 Nov 18.
4
Impact of celiac neurolysis on survival in patients with pancreatic cancer.腹腔神经丛阻滞对胰腺癌患者生存率的影响。
Gastrointest Endosc. 2015 Jul;82(1):46-56.e2. doi: 10.1016/j.gie.2014.12.036. Epub 2015 Mar 20.
5
McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma.可切除性胰头腺癌患者的麦吉尔-布里斯班症状评分
World J Gastroenterol. 2014 Sep 14;20(34):12226-32. doi: 10.3748/wjg.v20.i34.12226.
6
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.胰腺癌的诊断、治疗和姑息治疗的进展:1990-2010 年。
World J Gastroenterol. 2011 Feb 21;17(7):867-97. doi: 10.3748/wjg.v17.i7.867.
7
Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma.胰腺导管腺癌的术前分期和可切除性评估。
HPB (Oxford). 2004;6(1):5-12. doi: 10.1080/13651820310017093.
8
Resection of non-cystic adenocarcinoma in pancreatic body and tail.胰体尾非囊性腺癌切除术
World J Gastroenterol. 2006 Sep 21;12(35):5726-8. doi: 10.3748/wjg.v12.i35.5726.
9
Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.外分泌性胰腺癌:就诊时的症状及其与肿瘤部位和分期的关系。
Clin Transl Oncol. 2005 Jun;7(5):189-97. doi: 10.1007/BF02712816.